Urology
 |
|
12 june 2019 14:03:00 |
| Programmed Death-1 or Programmed Death Ligand-1 Blockade in Patients with Platinum-resistant Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis (European Urology) |
|
Tweet oRestricted mean survival time estimates may be used to benchmark survival outcomes and inform future trial design.oProgrammed death-1 and programmed death ligand-1 blockade in patients with platinum-resistant metastatic urothelial cancer yield comparable survival outcomes. |
| 82 viewsCategory: Urology |
 Perioperative and oncological outcomes of radical prostatectomy for high-risk prostate cancer in the UK: an analysis of surgeon-reported data (BJU International)Is Magnetic Resonance Imaging-targeted Biopsy Now the Standard of Care? (European Urology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page